Yesterday, Abbott reported that a two year study showed that:
a bioabsorbable stent successfully treated coronary artery disease and was absorbed within the walls of arteries.
It was proven by:
data from 30 patients showed the drug-eluting stent left behind blood vessels "that appeared to move and function similar to unstented arteries."
Eighty patients will be included in the next stage of the clinical trial and Abbott hopes to release this drug to the European market by 2012, followed by the United States.
Wednesday, October 15, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment